OBJECTIVES: Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's disease and five patients with progressive supranuclear palsy. The aim of the study was to assess the concentration of N-acetyl-aspartate (NAA), creatine and phosphocreatine (Cr), and choline containing compounds (Cho) in the putamen and globus pallidus of these patients. METHODS: Peak ratios obtained from patients were compared with those from nine healthy age matched controls. RESULTS: NAA/Cho and NAA/Cr ratios were reduced significantly in patients with progressive supranuclear palsy. CONCLUSION: These results suggest an NAA deficit, due to neuronal loss, in the lentiform nucleus of these patients. 1H-MRS is a non-invasive technique that can provide useful information concerning striatal neuronal loss in the basal ganglia of patients with parkinsonian syndromes.
OBJECTIVES: Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's disease and five patients with progressive supranuclear palsy. The aim of the study was to assess the concentration of N-acetyl-aspartate (NAA), creatine and phosphocreatine (Cr), and choline containing compounds (Cho) in the putamen and globus pallidus of these patients. METHODS: Peak ratios obtained from patients were compared with those from nine healthy age matched controls. RESULTS:NAA/Cho and NAA/Cr ratios were reduced significantly in patients with progressive supranuclear palsy. CONCLUSION: These results suggest an NAAdeficit, due to neuronal loss, in the lentiform nucleus of these patients. 1H-MRS is a non-invasive technique that can provide useful information concerning striatal neuronal loss in the basal ganglia of patients with parkinsonian syndromes.
Authors: C A Davie; G K Wenning; G J Barker; P S Tofts; B E Kendall; N Quinn; W I McDonald; C D Marsden; D H Miller Journal: Ann Neurol Date: 1995-02 Impact factor: 10.422
Authors: P Gideon; O Henriksen; B Sperling; P Christiansen; T S Olsen; H S Jørgensen; P Arlien-Søborg Journal: Stroke Date: 1992-11 Impact factor: 7.914
Authors: G Sinson; L J Bagley; K M Cecil; M Torchia; J C McGowan; R E Lenkinski; T K McIntosh; R I Grossman Journal: AJNR Am J Neuroradiol Date: 2001-01 Impact factor: 3.825
Authors: I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea Journal: J Neurol Neurosurg Psychiatry Date: 1998-04 Impact factor: 10.154
Authors: S D Taylor-Robinson; N Turjanski; S Bhattacharya; J P Seery; J Sargentoni; D J Brooks; D J Bryant; I J Cox Journal: Metab Brain Dis Date: 1999-03 Impact factor: 3.584
Authors: Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs Journal: Mov Disord Date: 2017-05-13 Impact factor: 10.338
Authors: M T Hu; S D Taylor-Robinson; K R Chaudhuri; J D Bell; R G Morris; C Clough; D J Brooks; N Turjanski Journal: J Neurol Neurosurg Psychiatry Date: 1999-07 Impact factor: 10.154